Cargando…
Design of novel disturbing peptides against ACE2 SARS-CoV-2 spike-binding region by computational approaches
The SARS-CoV-2, the virus which is responsible for COVID-19 disease, employs its spike protein to recognize its receptor, angiotensin-converting enzyme 2 (ACE2), and subsequently enters the host cell. In this process, the receptor-binding domain (RBD) of the spike has an interface with the α1-helix...
Autores principales: | Zareei, Sara, Pourmand, Saeed, Amanlou, Massoud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692113/ https://www.ncbi.nlm.nih.gov/pubmed/36438825 http://dx.doi.org/10.3389/fphar.2022.996005 |
Ejemplares similares
-
Inhibition of SARS-CoV-2 pathogenesis by potent peptides designed by the mutation of ACE2 binding region
por: Pourmand, Saeed, et al.
Publicado: (2022) -
A Repurposed Drug Screen Identifies Compounds That Inhibit the Binding of the COVID-19 Spike Protein to ACE2
por: Tsegay, Kaleb B., et al.
Publicado: (2021) -
SARS-CoV-2 spike and ACE2 entanglement-like binding
por: Pregnolato, Massimo, et al.
Publicado: (2023) -
Designing Short Peptides to Block the Interaction of SARS-CoV-2 and Human ACE2 for COVID-19 Therapeutics
por: Basit, Abdul, et al.
Publicado: (2021) -
Computationally engineered ACE2 decoy binds with nanomolar affinity with the SARS-CoV-2 spike protein
por: Islam, Mohammad S., et al.
Publicado: (2022)